Evidence map›Paper›PMID 33711248›Full record

ArticleAmerican journal of human genetics2021

Monoallelic and bi-allelic variants in NCDN cause neurodevelopmental delay, intellectual disability, and epilepsy.

Ambrin Fatima, Jan Hoeber, Jens Schuster, Eriko Koshimizu, Carolina Maya-Gonzalez, Boris Keren, Cyril Mignot, Talia Akram, Zafar Ali, Satoko Miyatake and 16 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A case of autoimmune cerebellar ataxia associated with anti-neurochondroitin antibody.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  5. Review
  6. Article
  7. Fine-Tuned Expression of Evolutionarily Conserved Signaling Molecules in theInternational journal of molecular sciences · 2024
    Article
  8. Journal of Cancer · 2024
    Article
  9. Article
  10. Functions and mechanisms of the GPCR adaptor protein Norbin.Biochemical Society transactions · 2023
    Review
  11. Article
  12. Article
  13. Effects of Two Distinct Psychoactive Microbes,International journal of molecular sciences · 2022
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 13 institutions in 4 countries.

Ambrin FatimaDepartment of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Box 815, 751 08 Uppsala, Sweden.
Jan HoeberDepartment of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Box 815, 751 08 Uppsala, Sweden.
Jens SchusterDepartment of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Box 815, 751 08 Uppsala, Sweden.
Eriko KoshimizuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Carolina Maya-GonzalezDepartment of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Box 815, 751 08 Uppsala, Sweden.
Boris KerenCenter for Molecular and Chromosomal Genetics APHP, Sorbonne University, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'Hôpital, 75013 Paris, France.
Cyril MignotCenter for Molecular and Chromosomal Genetics APHP, Sorbonne University, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'Hôpital, 75013 Paris, France.
Talia AkramDepartment of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Box 815, 751 08 Uppsala, Sweden; Human Molecular Genetics Laboratory, National Institute for Biotechnology and Genetic Engineering, Faisalabad 38000, Pakistan.
Zafar AliHuman Molecular Genetics Laboratory, National Institute for Biotechnology and Genetic Engineering, Faisalabad 38000, Pakistan.
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan; Clinical Genetics Department, Yokohama City University Hospital, Yokohama, Kanagawa 236-0004, Japan.
Junpei TanigawaDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Takayoshi KoikeNational Epilepsy Center, NHO Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka 420-8688, Japan.
Mitsuhiro KatoDepartment of Pediatrics, Showa University School of Medicine, Tokyo 142-8666, Japan.
Yoshiko MurakamiResearch Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Uzma AbdullahUniversity Institute of Biochemistry and Biotechnology, PMAS-Arid Agriculture University, Rawalpindi 46301, Pakistan.
Muhammad Akhtar AliSchool of Biological Sciences, University of the Punjab, Lahore 54590, Pakistan.
Rein FadoulDepartment of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Box 815, 751 08 Uppsala, Sweden.
Loora LaanDepartment of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Box 815, 751 08 Uppsala, Sweden.
Casimiro Castillejo-LópezDepartment of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Box 815, 751 08 Uppsala, Sweden.
Maarika LiikUnit of Clinical Neurophysiology, Uppsala University Hospital, 751 85 Uppsala, Sweden.
Zhe JinDepartment of Medical Cell Biology, Biomedical Centre, Uppsala University, 751 08 Uppsala, Sweden.
Bryndis BirnirDepartment of Medical Cell Biology, Biomedical Centre, Uppsala University, 751 08 Uppsala, Sweden.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Shahid M BaigHuman Molecular Genetics Laboratory, National Institute for Biotechnology and Genetic Engineering, Faisalabad 38000, Pakistan.
Joakim KlarDepartment of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Box 815, 751 08 Uppsala, Sweden.
Niklas DahlDepartment of Immunology, Genetics and Pathology, Uppsala University and Science for Life Laboratory, Box 815, 751 08 Uppsala, Sweden. Electronic address: niklas.dahl@igp.uu.se.
Uppsala University · SEScience for Life Laboratory · SENational Institute for Biotechnology and Genetic Engineering · PKOsaka University · JPYokohama City University · JPNational Epilepsy Center · JPPir Mehr Ali Shah Arid Agriculture University · PKPitié-Salpêtrière Hospital · FRShowa University · JPSorbonne Université · FRUniversity of the Punjab · PKUppsala University Hospital · SEYokohama City University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurochondrin (NCDN) is a cytoplasmatic neural protein of importance for neural growth, glutamate receptor (mGluR) signaling, and synaptic plasticity. Conditional loss of Ncdn in mice neural tissue causes depressive-like behaviors, impaired spatial learning, and epileptic seizures. We report on NCDN missense variants in six affected individuals with variable degrees of developmental delay, intellectual disability (ID), and seizures. Three siblings were found homozygous for a NCDN missense variant, whereas another three unrelated individuals carried different de novo missense variants in NCDN. We assayed the missense variants for their capability to rescue impaired neurite formation in human neuroblastoma (SH-SY5Y) cells depleted of NCDN. Overexpression of wild-type NCDN rescued the neurite-phenotype in contrast to expression of NCDN containing the variants of affected individuals. Two missense variants, associated with severe neurodevelopmental features and epilepsy, were unable to restore mGluR5-induced ERK phosphorylation. Electrophysiological analysis of SH-SY5Y cells depleted of NCDN exhibited altered membrane potential and impaired action potentials at repolarization, suggesting NCDN to be required for normal biophysical properties. Using available transcriptome data from human fetal cortex, we show that NCDN is highly expressed in maturing excitatory neurons. In combination, our data provide evidence that bi-allelic and de novo variants in NCDN cause a clinically variable form of neurodevelopmental delay and epilepsy, highlighting a critical role for NCDN in human brain development.

Indexed as

AllelesAdolescentBase SequenceCell LineChild, PreschoolConsanguinityEpilepsyFemaleHumansInfantIntellectual DisabilityLanguage Development DisordersMaleMutationMutation, MissenseNerve Tissue ProteinsNCDN protein, humanNerve Tissue Proteinsde novo variantepilepsyintellectual disabilitymGluR5 signalingmissense variantNCDN geneneurite formationneurodevelopmental delayspeech delay

Identifiers

PMID33711248
PMCPMC8059333
OpenAlexW3134306588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.